Vitara Biomedical
Series B in 2024
Vitara Biomedical is focused on developing a therapeutic platform designed to support premature infants. The company draws inspiration from natural physiological processes to improve neonatal care, aiming to enhance the quality of life for these vulnerable newborns. By addressing the unique challenges faced by premature infants, Vitara Biomedical seeks to reduce mortality rates and associated health complications, ultimately providing a foundation for a healthier future for both infants and their families.
Vitara Biomedical
Series B in 2022
Vitara Biomedical is focused on developing a therapeutic platform designed to support premature infants. The company draws inspiration from natural physiological processes to improve neonatal care, aiming to enhance the quality of life for these vulnerable newborns. By addressing the unique challenges faced by premature infants, Vitara Biomedical seeks to reduce mortality rates and associated health complications, ultimately providing a foundation for a healthier future for both infants and their families.
Embrace Global
Series A in 2013
Embrace Global is a healthcare technology company based in Bengaluru, India, focused on developing affordable medical devices for emerging markets. The company is known for its flagship product, the Embrace Nest, a portable infant warmer designed to assist low birth-weight and premature babies. This innovative solution offers a cost-effective alternative to traditional incubators, priced at less than 1% of current options, thereby addressing the critical need to reduce mortality rates among the estimated 20 million premature-birth-weight infants who die each year. In addition to its existing products, Embrace Global engages in research and development to create new low-cost innovations aimed at improving maternal and child health.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.